Efflux proteins and insulin resistance in atherogenesis

动脉粥样硬化中的外流蛋白和胰岛素抵抗

基本信息

  • 批准号:
    7406106
  • 负责人:
  • 金额:
    $ 64.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2008-03-31
  • 项目状态:
    已结题

项目摘要

CD36 is a broadly expressed 88 kD transmembrane glycoprotein which functions as a scavenger receptor, adhesion and signaling molecule and a facilitator of fatty acid transport. Previous work by our group and others determined that CD36 was a major mediator of macrophage foam cell formation and atherogenesis. Recently, a paradox has emerged: significant protection against lesion development and progression was observed in experimental conditions where CD36 was rendered absent genetically and when CD36 was upregulated by pharmacological means. Using stem cell transfer of CD36/apoE bone marrow into apoE null animals, we found that the atheroprotective effect afforded by complete absence of CD36 was not fully realized. Thus, a major hypothesis of this application is that CD36 has atheroprotective properties independent of its role as a scavenger receptor. Based on emerging data, we focus on the role of CD36 in efflux pathways and in modulating insulin-resistance, both of which are stimulated by drugs which activate PPARs, transcription factors which regulate CD36 expression. We hypothesize that CD36 is a critical player in maintenance of vessel wall homeostasis, and that entry of cholesterol into macrophages via CD36 facilitates removal of pro-atherogenic modified LDL from the intima, and ultimately allows lipid clearance through efflux pathways. Elucidation of the regulation of CD36 in relationship to the major efflux pathways is a major goal of our studies. Insulin resistance is a separate risk factor for atherogenesis and results in its premature development. We hypothesize that a portion of the protective role of CD36 in atherogenesis is related to its effect on glucose and fatty acid metabolism. We will utilize unique animal models we have on hand to explore the differential impact of CD36 on atherosclerosis based on scavenger receptor function or its role as a facilitator of fatty acid transport and determinant of insulin sensitivity. These approaches will enable us to design more specific treatment regimens which will ultimately impact on human health and disease.
CD 36是一种广泛表达的88 kD跨膜糖蛋白,具有清道夫受体、粘附分子、信号分子和脂肪酸转运促进剂的功能。我们小组和其他人以前的工作确定了CD 36是巨噬细胞泡沫细胞形成和动脉粥样硬化形成的主要介质。最近,出现了一个悖论:显着的保护病变的发展和进展,观察到在实验条件下,CD 36是呈现遗传缺乏和当CD 36被上调的药理学手段。用干细胞将CD 36/apoE骨髓移植到apoE缺失的骨髓中 在动物中,我们发现完全缺乏CD 36所提供的动脉粥样硬化保护作用没有完全实现。因此,本申请的一个主要假设是CD 36具有与其作为清道夫受体的作用无关的动脉粥样硬化保护特性。基于新出现的数据,我们专注于CD 36在外排途径和调节胰岛素抵抗中的作用,这两者都是由激活PPARs的药物刺激的,PPARs是调节CD 36表达的转录因子。我们假设CD 36是维持血管壁稳态的关键因素,胆固醇通过CD 36进入巨噬细胞有助于从内膜中清除促动脉粥样硬化修饰的LDL,并最终通过外排途径清除脂质。阐明与主要外排途径相关的CD 36调节 是我们研究的主要目标。胰岛素抵抗是动脉粥样硬化形成的独立危险因素,并导致其过早发展。我们推测CD 36在动脉粥样硬化形成中的保护作用部分与其对葡萄糖和脂肪酸代谢的影响有关。我们将利用我们手头上独特的动物模型,探索基于清道夫受体功能或其作为脂肪酸转运促进剂和胰岛素敏感性决定因素的作用,CD 36对动脉粥样硬化的不同影响。这些方法将使我们能够设计更具体的治疗方案,最终影响人类健康和疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID P HAJJAR其他文献

DAVID P HAJJAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID P HAJJAR', 18)}}的其他基金

Eicosanoid Regulation in Atherosclerosis: Involvement of Inducible NO Synthase
类二十烷酸在动脉粥样硬化中的调节:诱导型 NO 合酶的参与
  • 批准号:
    7353501
  • 财政年份:
    2009
  • 资助金额:
    $ 64.97万
  • 项目类别:
Eicosanoid Regulation in Atherosclerosis: Involvement of Inducible NO Synthase
类二十烷酸在动脉粥样硬化中的调节:诱导型 NO 合酶的参与
  • 批准号:
    7878597
  • 财政年份:
    2009
  • 资助金额:
    $ 64.97万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7218246
  • 财政年份:
    2006
  • 资助金额:
    $ 64.97万
  • 项目类别:
Oxidative Alterations of Cyclooxygenase in Atherogenesis
动脉粥样硬化中环加氧酶的氧化改变
  • 批准号:
    7218244
  • 财政年份:
    2006
  • 资助金额:
    $ 64.97万
  • 项目类别:
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION PROJECT: NEUROSCIENCE
校外研究设施建设项目:神经科学
  • 批准号:
    6973018
  • 财政年份:
    2004
  • 资助金额:
    $ 64.97万
  • 项目类别:
RR-03-011 Extramural Research Facilities Construction P*
RR-03-011 校外研究设施建设 P*
  • 批准号:
    6860553
  • 财政年份:
    2004
  • 资助金额:
    $ 64.97万
  • 项目类别:
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION PROJECT: AIDS
校外研究设施建设项目:艾滋病
  • 批准号:
    6973019
  • 财政年份:
    2004
  • 资助金额:
    $ 64.97万
  • 项目类别:
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION PROJECT: BIOCHEMISTRY
校外研究设施建设项目:生物化学
  • 批准号:
    6973016
  • 财政年份:
    2004
  • 资助金额:
    $ 64.97万
  • 项目类别:
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION PROJECT: GENETICS
校外研究设施建设项目:遗传学
  • 批准号:
    6973017
  • 财政年份:
    2004
  • 资助金额:
    $ 64.97万
  • 项目类别:
Program Project: The Atherogenic Microenvironment
计划项目:致动脉粥样硬化微环境
  • 批准号:
    7228514
  • 财政年份:
    2003
  • 资助金额:
    $ 64.97万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 64.97万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 64.97万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 64.97万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 64.97万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 64.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 64.97万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 64.97万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 64.97万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 64.97万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 64.97万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了